FOSUN HEALTH Logo

Breast Nodules Diagnosis

catalogue

Breast Nodules Diagnosis

Breast Nodules Diagnosis

A breast lump is assessed by a sequence so standard that it has a name: triple assessment. Three independent ways of looking at the same lump — what it feels like, what it looks like, and what it is made of — are combined into one conclusion, and the design is deliberate: each of the three can be reassuring on its own and wrong on its own, and it is the agreement between them that makes a conclusion trustworthy. The sequence also has a built-in vocabulary, the BI-RADS category, which converts a scan finding into a standardised level of concern and tells every clinician who reads it afterwards what happens next. This page walks the sequence in order: what the examination feels for, which imaging test is used first and why age decides it, what the BI-RADS categories mean, what a needle biopsy actually involves, and what each kind of result sets in motion.

The clinical examination: what the hand is feeling for

The first instrument used on a breast lump costs nothing and discriminates well. The examination answers questions the machines later refine:

  • Lump or texture — is there a discrete lump with edges, or a general nodularity that spreads beyond one spot? The distinction made here shapes everything downstream.
  • Surface and edge — smooth and round leans towards cyst or fibroadenoma; irregular and ill-defined leans towards needing imaging and a closer look.
  • Consistency and mobility — soft or rubbery and slipping under the fingers is the classic benign feel; hard, or apparently tethered to the tissue or skin around it, raises the tempo.
  • The surround — the skin for dimpling or puckering, the nipple for position and discharge, and both armpits and the lower neck for lymph nodes. A breast examination that stops at the breast is half done.
  • Both breasts, always — comparing one side against the other is what separates a genuine new lump from a patient’s own familiar, lumpy normal.

What the examination cannot do is settle the question alone. A classic-feeling fibroadenoma is still confirmed by imaging, and often by biopsy, before anyone uses the word benign with conviction — that is the entire discipline of triple assessment.

Which scan first, and why age decides

The two standard imaging tests read breast tissue differently, and the tissue itself changes with age — which is why the first test is chosen mainly by age:

  • Breast ultrasound — the first choice in women under about thirty-five to forty, during pregnancy and breastfeeding, and in men. Young breast tissue is dense, and dense tissue reads beautifully on ultrasound and poorly on mammography; ultrasound also separates fluid from solid in seconds, which is the single most useful division in this whole subject.
  • Mammography — the first choice from about the age of forty, when breast tissue begins to be replaced by fat that mammography reads well. It shows microcalcification — tiny calcium specks — that ultrasound cannot see, and it is the test on which population screening is built.
  • Both together — in women over about forty the two are often used in the same assessment, because they answer complementary questions: mammography for calcification and overall architecture, ultrasound for the lump itself.
  • With implants — both tests remain usable with implant-aware techniques; the implant is not a barrier to assessment, only a reason to say so when booking.

The age threshold is a convention, not a wall: either test can be ordered at any age when the question calls for it. What the convention prevents is the young woman whose dense tissue makes a mammogram unreadable and falsely reassuring.

The BI-RADS category: turning a picture into a plan

Every imaging finding is given a category on a standard scale, so that the level of concern is written into the report itself and every clinician who reads it later knows what was thought and what should follow:

Category What it means What usually follows
0 Incomplete — the images do not yet answer the question More images, or comparison with older films, before anything is concluded
1 Nothing to report Routine screening at the usual interval
2 Definitely benign — a simple cyst, a classic lymph node, a long-stable nodule No further work-up for the finding itself
3 Probably benign Short-interval imaging follow-up at defined intervals instead of biopsy
4 Suspicious — not classic for anything, so tissue is needed Needle biopsy, subdivided by level of suspicion
5 Highly suggestive of malignancy Biopsy and, in parallel, planning that assumes a serious answer until proven otherwise

The value of the scale is that it removes improvisation. A category 3 finding is not a shrug — it is a commitment to a defined follow-up schedule; a category 4 is a written trigger for tissue. Patients reading their own reports should read the category first and the prose second.

The needle biopsy: what it involves and what it is for

When imaging leaves real doubt, the question is closed with tissue. Two instruments do nearly all of this work:

  • Fine needle aspiration — a very thin needle, without injection of local anaesthetic in most cases, draws cells or fluid. For a cyst it empties the lump and the lump disappears, ending the matter; for a solid lump it provides cells for the cytologist.
  • Core needle biopsy — a slightly thicker needle, always under local anaesthetic, taking small slivers of tissue that preserve architecture. It is the standard for solid lumps because knowing what cells are present and how they are arranged is what separates benign tissue from atypia and from cancer.
  • Image guidance — the needle is aimed by ultrasound in real time wherever the lump can be seen on it, which is most of the time; accuracy is the point of the machinery.
  • What it feels like — pressure and a clicking sensation, a few seconds of discomfort with each core, and a bruise afterwards. It is a clinic procedure, not an operation, and the patient walks out afterwards.
  • A marker clip — where a lump will be followed or removed later, a tiny metal clip is often left at the biopsy site so the same spot can be found again with certainty.

One fear deserves a direct answer: a needle biopsy does not spread a cancer. The evidence behind modern image-guided needle techniques is what allowed them to replace open surgical biopsy decades ago, and the question, though natural, is settled.

Reading the result: the four kinds of answer

A completed assessment produces one of four conclusions, and each sets a different plan in motion:

  • Benign — the three steps agree and the answer is fibroadenoma, cyst, fibrocystic change or another harmless explanation. The plan is explanation plus a structured review, not surgery.
  • Atypical — the tissue is not cancer but is not entirely normal either: cells that have started along a pathway. This is a genuine finding that needs a conversation about removal or closer surveillance, decided case by case.
  • Malignant — cancer found, and found by this process early. The assessment has done its job; care continues immediately in the breast cancer programme with staging and a full multidisciplinary plan.
  • Discordant — the biopsy result and the imaging disagree, for instance a benign sample from a lump that looked suspicious. A discordant result is treated as unresolved: the biopsy is repeated or the lump is removed, because when the steps disagree, one of them is wrong and it is never assumed to be the reassuring one.

The honest summary: most assessments end in the first line, a minority end in the third, and the system is engineered so that the difference is discovered by needle rather than by waiting.

Your assessment, in order

Putting the sequence together as it runs in practice:

  • Step one — the examination. Both breasts and the lymph node areas, with the history: when the lump appeared, whether it changes with the cycle, what hormone therapy is being taken.
  • Step two — the right first scan. Ultrasound, mammography or both, chosen by age and tissue, reported with a BI-RADS category.
  • Step three — the needle, if and as indicated. Fine needle for fluid, core needle for solid lumps, aimed by ultrasound.
  • Step four — the conclusion, read together. Benign, atypical, malignant or discordant, and a plan written for each: review schedule, surgery, or immediate oncology referral.
  • Step five — the record. Images and reports kept, so that any future change is measured against a documented baseline rather than a memory.

For an international patient, the first four steps can usually be completed within one short visit, with the imaging read while you are still in the clinic and the biopsy, where needed, taken the same day — so that the flight home carries a conclusion rather than an appointment.

Frequently Asked Questions

Will a needle biopsy spread a lump or make things worse?

No. This fear is understandable and the question has been studied extensively: modern image-guided needle biopsy does not spread breast cancer, which is precisely why it replaced open surgical biopsy as the standard decades ago. The information it provides is worth far more than the small bruise it may leave.

Why do I need both a mammogram and an ultrasound?

Because they see different things. Mammography shows overall architecture and microcalcification that ultrasound misses; ultrasound shows a specific lump in detail and separates fluid from solid. In women over about forty the two together are the complete picture, and a finding on one often needs the other to be placed.

What does probably benign mean — is watching it really safe?

Category 3, probably benign, is a defined and studied pathway, not a shrug. It applies to findings with a characteristic benign appearance, and it means short-interval imaging to confirm stability — chosen precisely where biopsy would put thousands of needles into lumps that behave identically without one.

How long do biopsy results take, and what happens while I wait?

Pathology needs some days to process and report tissue properly; anything promising an instant tissue answer is cutting corners. A sensible pathway tells you when the result will be discussed — and a good one books that appointment before you leave, so the waiting has an end date.

Have your imaging read and your sequence completed in one visit

Send the imaging itself — the images, not only the reports — together with any biopsy pathology and your age. A written opinion on which test comes first for you, what the current imaging shows, and whether a needle is likely to be needed follows within about 48 hours of complete records arriving.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*